ArticleArthroplasty today2026
Predicting 5-Year Mortality After Prosthetic Joint Infection Using a 30-Item Accumulated Frailty Index in a 13,371-Patient Multicenter Cohort.
Article in Arthroplasty today, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Prosthetic joint infection (PJI) involves a significant mortality risk, with 26-30% of patients dying within 5 years. Current risk assessment tools offer limited prognostic accuracy for PJI patients. This study aimed to develop a prognostic model for 5-year all-cause mortality after PJI using age and frailty assessments. Methods: We conducted a retrospective cohort study using TriNetX electronic health record data from 13,371 PJI patients diagnosed before 2021. We developed a 30-item Accumulated Frailty Index (AFI-Core30) that incorporates comorbidities, physiologic deficits, medications, and functional status. Generalized additive modeling was used to predict 5-year mortality, with 80% of data allocated for training and 20% for validation. Model performance was assessed using discrimination metrics and calibration techniques. Results: The mean patient age was 63.1 ± 11.4 years, with an overall 5-year mortality rate of 13.1%. Both AFI-Core30 and age independently predicted mortality (odds ratio per 0.1 AFI increase = 1.84, 95% confidence interval: 1.74-1.95, Conclusions: This validated prognostic model offers the first large-scale, frailty-based tool for predicting mortality in PJI patients. The framework allows for evidence-based risk assessment and personalized treatment planning, shifting PJI prognostication from subjective judgment to objective risk measurement for better clinical decision-making.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.